date:Jun 16, 2012
eye health is too strong to reject the claim: We have no doubt that EFSA would have given the claim an outright rejection if it had felt the evidence was too weak.
DSM and Kemin will seek dialogue with EFSA and potentially the commission to better understand the balance between a number of the factors identified in the opinion: What is the relative importance of the choice of the end-point, the claim wording and the evidence on the mechanisms?
Kemin president Pedro Vieira added:The dossier co